| 10008128 |
10(S),17(S)-DiHDoHE
Exclusive
|
|
871826-47-0 |
≥98%
|
|
✓ |
2007-08-21
|
106.761685082873
|
10-s-17-s-dihdohe
|
PDX; Protectin DX
|
inflammation resolution resolvins neuroprotection neurodegeneration Alzheimer's disease NPD1 PD1 RvE1 dihydroxy DHA 10S,17S dihydroxy DHA anti-inflammatory neuroprotectin d1 protectin d1 10(s), 17(s)-dihdohe protectin-dx protectindx |
106.761685082873
|
| 20140 |
12-oxo Leukotriene B4
|
|
136696-10-1 |
≥95%
|
|
|
2009-03-06
|
26.550049723756
|
12-oxo-leukotriene-b4
|
12-keto LTB4; 12-oxo LTB4
|
LTB4 metabolism PMNL neutrophils inflammation chemotaxis chemokinesis 12-keto leukotriene B4 12-keto-leukotriene B4 |
26.550049723756
|
| 10010132 |
15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester
|
|
- |
≥98% (isomer mixture)
|
|
|
2008-06-09
|
19.581055862492
|
15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester
|
15-deoxy-Δ12,14-PGJ2-2-glycerol ester
|
PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic |
19.581055862492
|
| 10080 |
16,16-dimethyl Prostaglandin A1
|
|
41692-24-4 |
≥98%
|
|
|
|
72.236740331491
|
16-16-dimethyl-prostaglandin-a1
|
16,16-dimethyl PGA1
|
16,16-dimethyl-pga1 prostaglandins metabolism-resistant analogs inhibits inhibition inhibitors viral replication HSV HIV-1 herpes simplex virus human immunodeficiency type 1 |
72.236740331491
|
| 13060 |
17(R)-Resolvin D1
Exclusive
|
|
528583-91-7 |
≥95%
|
|
✓ |
2008-12-18
|
127.184952347746
|
17-r-resolvin-d1
|
AT-RvD1; 17(R)-RvD1; Aspirin-triggered-Resolvin D1
|
EPAs DHAs resolvins inflammation antiinflammatory anti-inflammatory immune response aspirin LOXs 17R ATRvD1 17RRvD1 10007848 |
127.184952347746
|
| 10010094 |
1-Palmitoyl Lysophosphatidic Acid
|
|
22002-85-3 |
≥98%
|
|
|
2010-11-29
|
9.517127071823
|
1-palmitoyl-lysophosphatidic-acid
|
1-Palmitoyl LPA (free acid)
|
GPCR G-proteins cells proliferation smooth muscles contractions platelets aggregation |
9.517127071823
|
| 10010290 |
1-Palmitoyl Lysophosphatidic Acid (sodium salt)
Exclusive
|
|
- |
>98%
|
|
✓ |
2007-09-05
|
16.371922651933
|
1-palmitoyl-lysophosphatidic-acid-sodium-salt
|
1-Palmitoyl LPA
|
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate monopalmitoylphosphatidic acid MPPA LPAS GPCRs biological responses |
16.371922651933
|
| 13222 |
2-Acetyl-5-tetrahydroxybutyl Imidazole
|
|
94944-70-4 |
≥95%
|
|
|
2009-10-08
|
42.741312154696
|
2-acetyl-5-tetrahydroxybutyl-imidazole
|
THI; 2-ATHBI; 2-Acetyl-4-tetrahydroxybutyl Imidazole
|
sphingosines-1-phosphates S1P lyases S1PL inhibitors lymphatic tissues lymphocytes egress thymus lymphoid organs lymphopenia immunosuppression THI |
42.741312154696
|
| 10007980 |
3,4-DAA
|
|
- |
≥95%
|
|
|
2006-08-09
|
1.842265193370
|
3-4-daa
|
|
Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines |
1.842265193370
|
| 9000786 |
3-Deaza-2'-deoxyadenosine
|
|
78582-17-9 |
≥98%
|
|
|
2011-06-15
|
60.266809392265
|
3-deaza-2-deoxyadenosine
|
c3dA
|
inhibitors genes regulation immunology lymphocytes cytolysis nucleosides adenine nitrogen DNA |
60.266809392265
|
| 10006618 |
5-OxoETE Receptor Blocking Peptide
|
|
- |
|
|
|
2005-03-07
|
0E-12
|
5-oxoete-receptor-blocking-peptide
|
TG1019; R527
|
antibodies western blotting blots signaling signalling WB ICC immunocytochemistry 5-oxo-ETE receptors controls peptides proteins eicosatetraenoic acids PUFAs polyunsaturated fatty |
0E-12
|
| 100025 |
5-OxoETE Receptor Polyclonal Antibody
|
|
- |
|
|
|
2004-12-14
|
255.799907918968
|
5-oxoete-receptor-polyclonal-antibody
|
TG1019; R527
|
WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting |
255.799907918968
|
| 90420 |
5(S),14(R)-Lipoxin B4
|
|
98049-69-5 |
>95%
|
|
|
2008-11-17
|
36.819287906691
|
5-s-14-r-lipoxin-b4
|
5(S),14(R)-LXB4
|
LXB4 trihydroxy fatty acids leukocyte activation LXA4 inflammation lipoxins inhibits inhibition inhibitiors |
36.819287906691
|
| 90415 |
5(S),6(R),15(R)-Lipoxin A4
|
|
171030-11-8 |
≥95%
|
|
|
2008-11-17
|
107.479164364641
|
5-s-6-r-15-r-lipoxin-a4
|
5(S),6(R),15(R)-LXA4; AT-Lipoxin A4; 15-epi Lipoxin A4
|
inflammations lipoxins aspirins ASA neutrophils inflammatory aspirins triggered |
107.479164364641
|
| 10049 |
5(S),6(S)-Lipoxin A4
|
|
- |
>95%
|
|
|
2004-06-29
|
106.148812154696
|
5-s-6-s-lipoxin-a4
|
5(S),6(S),15(S)-TriHETE; 5(S),6(S)-LXA4
|
LXA4 lipoxins trihydroxy fatty acids leukocytes activation 11-cis isomers |
106.148812154696
|
| 10546 |
7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid
Exclusive
|
|
887752-13-8 |
≥98%
|
|
✓ |
2010-10-22
|
4.518093922651
|
7-s-17-s-dihydroxy-8-e-10-z-13-z-15-e-19-z-docosapentaenoic-acid
|
7(S),17(S)-hydroxy DPA
|
opxylipin docosanoid DPAs DHAs protectins D1 anti-inflammatory fatty acids |
4.518093922651
|
| 11308 |
Anisomycin
New
|
|
22862-76-6 |
≥98%
|
|
|
2012-02-13
|
29.177773401653
|
anisomycin
|
NSC 76712; Flagecidin; Wuningmeisu C
|
2322-08-9 11023-48-6 antibiotics inhibitors proteins DNA stress-activated kinases MAP caspase-8 cancers immunology immunosuppressant pyrrolidines Streptomyces griseolus synthesis signal transduction pathways T cells skin mice anoikis epithelial apoptosis ECM distal tumors prostate metastasis NSC76712 NSC-76712 |
29.177773401653
|
| 500840 |
Anti-Ovalbumin IgE (mouse) EIA Kit
New
|
|
- |
|
|
|
2012-02-14
|
46.808728740115
|
anti-ovalbumin-ige-mouse-eia-kit
|
|
EIAs ELISAs enzymes immunoassays immunometric kits assays measures measurements immunizations mice mouse with chicken egg albumin OVA precipitate complexes aluminum hydroxides alum TH2-mediated immune immunity response OVA/alum immunized anti-OVA antibody antibodies IgG1 isotypes mediates tissues tissue-specific effectors models chronic inflammation allergy allergic asthma rhinitis cutaneous hypersensitivity levels plasma serum blood immunoglobulin OVA-specific plate-bound biotin-labeled monoclonal |
46.808728740115
|
| 500830 |
Anti-Ovalbumin IgG1 (mouse) EIA Kit
|
|
- |
|
|
|
2011-11-21
|
81.754843281696
|
anti-ovalbumin-igg1-mouse-eia-kit
|
|
EIAs enzymes immunoassays immunometric kits assays measures measurements eggs whites immunization mice mouse chickens albumin OVA precipitate complexes aluminum hydroxides alum TH2-mediated immune response immunity OVA/alum immunized anti-OVA antibodies IgG1 IgE isotypes mediate tissue-specific tissues effectors chronic inflammation allergic asthma rhinitis cutaneous hypersensitivity antibody plasma serum immunoglobulin OVA-specific TH2 |
81.754843281696
|
| 10008612 |
azido-FTY720
|
|
- |
≥98%
|
|
|
2006-09-13
|
52.768238182934
|
azido-fty720
|
|
sphingosine 1 phosphate S1P1 S1P3 S1P4 S1P5 immunosuppressant kinases photoreactive agonists analogs allograft transplants inhibits inhibitors inhibition lymphocytes emigration lymphoid organs in vivo Azido FTY720 FTY 720 |
52.768238182934
|
| 10010266 |
BAY-11-7082
|
|
19542-67-7 |
≥98%
|
|
|
2008-07-25
|
33.128187845303
|
bay-11-7082
|
|
inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 |
33.128187845303
|
| 120112 |
BLT1 Receptor Blocking Peptide
|
|
- |
~30%
|
|
|
|
2.192541436464
|
blt1-receptor-blocking-peptide
|
Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1
|
BLT-1 receptors leukotrienes controls peptides flow cytometry FACS ICC immunocytochemistry antibodies |
2.192541436464
|
| 120111 |
BLT1 Receptor Monoclonal Antibody (Clone 7B1)
|
|
- |
|
|
|
|
27.399629044988
|
blt1-receptor-monoclonal-antibody-clone-7b1
|
Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1
|
LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc immunohistochemistry ihc atherosclerosis FC |
27.399629044988
|
| 120114 |
BLT1 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
6.180524861878
|
blt1-receptor-polyclonal-antibody
|
Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1
|
LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc atherosclerosis immunoblotting FC |
6.180524861878
|
| 100019 |
BLT1 Receptor Polyclonal Antiserum
|
|
- |
|
|
|
|
2.877071823204
|
blt1-receptor-polyclonal-antiserum
|
Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1
|
C-terminus C-terminal intracellular plasma membranes whole cells LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc chronic pancreatitis pancreatic cancers pancreas atherosclerosis immunoblotting FC |
2.877071823204
|
| 320124 |
BLT2 Receptor Blocking Peptide
|
|
- |
|
|
|
|
6.357834254143
|
blt2-receptor-blocking-peptide
|
Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2
|
peptides controls receptors leukotrienes immunofluorescence flow cytometry FACs WB western blotting blots antibodies |
6.357834254143
|
| 120124 |
BLT2 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
122.215911602209
|
blt2-receptor-polyclonal-antibody
|
Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2
|
LTB4R2 LTB4-R2 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera western blots blotting WB atherosclerosis immunoblotting |
122.215911602209
|
| 13704 |
Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55-10)
|
|
- |
|
|
|
2009-11-12
|
6.408839779006
|
cav3-2-calcium-channel-monoclonal-antibody-clone-s55-10
|
|
antibodies CACNA1H genes epilepsy up-regulations up regulations upregulations prostate cancers androgen-independent androgen independent western blotting blots WB fusion protein immunohistochemistry IHC immunocytochemistry ICC |
6.408839779006
|
| 10005033 |
CAY10444
Exclusive
|
|
298186-80-8 |
≥98%
|
|
✓ |
2004-10-05
|
58.748941068140
|
cay10444
|
BML-241
|
receptors antagonists S1P3 EDG3 sphingosines sphingosine-1 sphingosine1 phosphates Hela cells G-proteins CAY-10444 BML241 |
58.748941068140
|
| 10009078 |
CAY10505
|
|
328960-84-5 |
≥98%
|
|
|
2009-11-04
|
7.700023327194
|
cay10505
|
|
phosphoinositide 3-kinase immunity autoimmune inflammation PI3Kγ PI3Kα PI3Kβ PI3Kδ casein kinases 2 CK2 phosphorylation PKB/Akt macrophages neutrophil recruitment cancer PI3s T2Ds PI3Ks PI3K.gamma. PI3Kg |
7.700023327194
|
| 10011248 |
CAY10575
|
|
916985-21-2 |
≥95%
|
|
|
2008-09-03
|
24.234925019731
|
cay10575
|
|
IKKε IKK-ε IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition NF-κB |
24.234925019731
|
| 10011249 |
CAY10576
|
|
862812-98-4 |
≥95%
|
|
|
2008-09-08
|
31.565377532228
|
cay10576
|
|
IKK-.epsilon. IKK.epsilon. IKK-epsilon IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition |
31.565377532228
|
| 16838 |
CAY10581
Exclusive
|
|
1018340-07-2 |
≥97%
|
|
✓ |
2009-05-08
|
2.261049723757
|
cay10581
|
|
indoleamine 2,3-dioxygenase IDO cancers inhibitors tumors inhibition inhibited naphthoquinones |
2.261049723757
|
| 10012424 |
CAY10583
Exclusive
|
|
862891-27-8 |
≥98%
|
|
✓ |
2009-07-21
|
61.190257826887
|
cay10583
|
|
LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation |
61.190257826887
|
| 13181 |
CAY10590
Exclusive
|
|
1101136-50-8 |
≥98%
|
|
✓ |
2009-04-15
|
14.872604577742
|
cay10590
|
|
sPLA2 cPLA2 iPLA2 phospholipases inhibitors R-gamma-nonleucine inhibition inhibited secreetory regulates phagocytosis foam cells |
14.872604577742
|
| 10012553 |
CAY10595
Exclusive
|
|
916047-16-0 |
≥97%
|
|
✓ |
2009-07-08
|
8.011823204419
|
cay10595
|
|
DP2 PGD2 CRTH2 chemotaxis inflammation antagonists prostaglandins PGDs |
8.011823204419
|
| 10012539 |
CAY10597
|
|
916046-55-4 |
≥98%
|
|
|
2009-03-11
|
3.705348066298
|
cay10597
|
|
DP2 PGD2 CRTH2 chemotaxis inflammation antagonist 5-chloro-1'-[(2-fluorophenyl)methyl]-2,2',5'-trioxo-spiro[3H-indole-3,3'-pyrrolidine-1(2H)-acetic acid |
3.705348066298
|
| 13615 |
CAY10614
Exclusive
|
|
1202208-36-3 |
≥98%
|
|
✓ |
2010-03-22
|
11.377624309392
|
cay10614
|
|
1115270-65-9 Lipids A endotoxins lipopolysaccharides LPS gram-negative bacterias infections toll-like receptor 4 TLR4 immune responses antagonists sepsis inflammation |
11.377624309392
|
| 10743 |
CAY10650
Exclusive
|
|
1233706-88-1 |
≥98%
|
|
✓ |
2011-06-14
|
12.111933701657
|
cay10650
|
|
cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 |
12.111933701657
|
| 10857 |
CAY10654
Exclusive
|
|
1298023-69-4 |
≥98%
|
|
✓ |
2011-06-21
|
1.903637200736
|
cay10654
|
|
CAY-10654 CAY 10654 quorum sense sensing signal signaling genes regulations infectious diseases lipids bacteria pseudomonas aeruginosa AHLs p. N-acylated-L-Homoserine lactones transcriptional activators LasR virulence factors immunosuppression leukocytes lymphocytes concanavalin A cytotoxicity |
1.903637200736
|
| 10004804 |
CD150 Monoclonal Antibody (Clone IPO-3)
|
|
- |
|
|
|
2005-03-21
|
1.228687845303
|
cd150-monoclonal-antibody-clone-ipo-3
|
SLAM; IPO-3; CDw150
|
type transmembrane glycoproteins signals signalling transduction neoplastic cells antibodies antisera antiserum antioncogenic immunohistochemistry IHC flow cytometry immunoprecipitation IP immunocytochemistry ICC receptors ligation Hodgkins lymphoma leukemia tumors cancer ipo3 cd-150 b-cells t-cells tonsils cancers FC |
1.228687845303
|
| 10004716 |
CD19 Monoclonal Antibody (Clone CB19)
|
|
- |
|
|
|
2004-08-02
|
0.594051565377
|
cd19-monoclonal-antibody-clone-cb19
|
B4
|
proteins antibodies antisera antiserum activation malignant leukemias lymphomas glycoproteins B-lymphocytes B-cell Bcell antigens immunocytochemistry ICC immunohistochemistry IHC frozen tissue sections FTS flow cytometry FC |
0.594051565377
|
| 10339 |
CD25 Monoclonal PE Antibody (Clone 143-13)
Exclusive
|
|
- |
|
|
✓ |
2010-06-09
|
18.849134438305
|
cd25-monoclonal-pe-antibody-clone-143-13
|
p55; IL-2Rα; Tac; Interleukin-2 receptor α subunit
|
antibodies antiserum IF FC flow cytometry immunofluorescence interleukins 2 IL-2 IL2 cytokines immunochemical IF |
18.849134438305
|
| 10004837 |
CD27 Monoclonal Antibody (Clone 203.6)
|
|
- |
|
|
|
2005-09-16
|
7.595037669512
|
cd27-monoclonal-antibody-clone-203-6
|
|
antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type II transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC |
7.595037669512
|
| 10004835 |
CD34 Monoclonal Antibody (Clone ICO-115)
|
|
- |
|
|
|
2005-09-16
|
4.551806204844
|
cd34-monoclonal-antibody-clone-ico-115
|
|
antibodies antisera antiserum ICC immunocytochemistry FACS flow cytometry type I transmembranes glycoproteins proteins antigens isoforms stem cells embryonic fibroblasts neurons Anti-CD34 differential staining acute leukemias cancers malignant malignancies ICO115 FC |
4.551806204844
|
| 300011 |
CD36 Blocking Peptide
|
|
- |
|
|
|
|
13.679737569060
|
cd36-blocking-peptide
|
Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb
|
type scavengers receptors atherosclerotic lesions glycoprotiens membranes PPAR.gamma. PPARgamma CD-36 western blots blotting atherosclerosis controls peptides peroxisome proliferator-activated GP-IV GP-4 GP-3b GP-IIIb |
13.679737569060
|
| 188150 |
CD36 Monoclonal Antibody (Clone JC63.1)
|
|
- |
|
|
|
|
19.629787505311
|
cd36-monoclonal-antibody-clone-jc63-1
|
Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb
|
antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC |
19.629787505311
|
| 10009893 |
CD36 Monoclonal Antibody (Clone JC63.1) (azide free)
Exclusive
|
|
- |
|
|
✓ |
2010-03-03
|
22.701510128913
|
cd36-monoclonal-antibody-clone-jc63-1-azide-free
|
GPIV; oxLDL; Thrombospondin Receptor; Hexarelin Receptor; GPIIIb
|
antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC leukemia lymphocytic |
22.701510128913
|
| 100011 |
CD36 Polyclonal Antibody
|
|
- |
|
|
|
|
38.341979742172
|
cd36-polyclonal-antibody
|
Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb
|
type scavengers receptors atherosclerotic lesions glycoprotiens membranes PPAR.gamma. PPARgamma antibodies atherosclerosis CD-36 western blots blotting peroxisome proliferator-activated GP-IIIb GP-IV GP-3b GP-4 WB atherosclerosis immunoblotting |
38.341979742172
|
| 10004718 |
CD37 Monoclonal Antibody (Clone IPO-24)
|
|
- |
|
|
|
2005-09-16
|
5.043556002008
|
cd37-monoclonal-antibody-clone-ipo-24
|
|
antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type III transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC |
5.043556002008
|
| 10004597 |
CD45 Monoclonal Antibody (Clone BRA-55)
|
|
- |
|
|
|
2005-08-23
|
5.043556002008
|
cd45-monoclonal-antibody-clone-bra-55
|
|
antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type transmembranes glycoproteins leukocytes antigens alternative splicing isoforms CD45RA CD45RB CD45RC CD45RO expression lymphocytes cells NK activated memory monocytes granulocytes dendritic anti-CD45 mAB lymphoid malignancies malignant cancer BRA55 immunoblotting FC |
5.043556002008
|
| 10009852 |
CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT-8)
|
|
- |
|
|
|
2008-09-03
|
0.417248618784
|
cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8
|
|
antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 IF immunofluorescence |
0.417248618784
|
| 10004599 |
CD4 Monoclonal Antibody (Clone RIV7)
|
|
- |
|
|
|
2005-08-03
|
4.049455406471
|
cd4-monoclonal-antibody-clone-riv7
|
|
proteins antibodies antisera antiserum flow cytometry FACS immunocytochemistry ICC immunohistochemistry IHC transmembranes glycoproteins thymocytes T cells subpopulations antigens MHC class II molecules monocytes dendritic tissues macrophages granulocytes lymphocytes T-helper regulatory suppressor FC |
4.049455406471
|
| 10010530 |
CD4 Monoclonal FITC Antibody (Clone RIV7)
|
|
- |
|
|
|
2007-11-24
|
0.404419889502
|
cd4-monoclonal-fitc-antibody-clone-riv7
|
|
antibodies antigens MHC molecules monocytes dendritic cells macrophages granulocytes T lymphocytes T cells |
0.404419889502
|
| 10011432 |
CD74 Monoclonal Antibody (Clone PIN1)
|
|
- |
|
|
|
2008-04-23
|
4.224514601420
|
cd74-monoclonal-antibody-clone-pin1
|
|
chaperones class II MHC N-terminal N-terminus ER molecules proteins expressions WB IP FC western blots immunoblotting immunoprecipitation flow cytometry ICC immunocytochemistry blotting |
4.224514601420
|
| 10004715 |
CD8 Monoclonal Antibody (Clone RIV11)
|
|
- |
|
|
|
2005-01-19
|
1.320331491712
|
cd8-monoclonal-antibody-clone-riv11
|
|
proteins antibodies antisera antiserum immunocytochemistry ICC immunohistochemistry IHC frozen tissue sections FTS flow cytometry type I transmembrane glycoprotein thymocytes blood T cells and NK cytotoxic major histocompatibility complex I molecules MHC FC |
1.320331491712
|
| 10004604 |
CD95 Monoclonal Antibody (Clone IPO-4)
|
|
- |
|
|
|
2004-06-17
|
2.077012891344
|
cd95-monoclonal-antibody-clone-ipo-4
|
APT; Apoptosis Antigen; TNFRSF6; Tumor Necrosis Factor Receptor Superfamily, Member 6; Fas; APO-1
|
glycoproteins blots blotting antibodies antisera antiserum DNA binding anti-oncogenic apoptosis cancers p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic immunocytochemistry immunohistochemistry IHC icc FC flow cytometry |
2.077012891344
|
| 10009853 |
CFSE Cell Division Assay Kit
|
|
- |
|
|
|
2010-01-15
|
63.844708882277
|
cfse-cell-division-assay-kit
|
|
derivative carboxyfluorescein diacetate, succinimidyl ester CFDA-SE cells proliferation growth factors receptors surfaces signaling molecules transcription factors DNA deoxyribonucleases proteins divisions cascades human pathological diseases cancers cell-tracing fluorescent fluorescence dyes proliferative activity parent generations daughter acetate groups molecules cleaved background unstained staining CFSE-labeled radioactivity radioactive labeling divisions inductions inhibitors inhibits inhibitions in vitro models flow cytometry fluorochromes fluorescein |
63.844708882277
|
| 10325 |
Chemokine-Like Receptor 1 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-25
|
63.879109883364
|
chemokine-like-receptor-1-polyclonal-antibody
|
GPCR ChemR23; Resolvin E1 Receptor; ChemerinR; DEZ; CMKLR1; ChemR23
|
immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR |
63.879109883364
|
| 10858 |
Cinnamyl-3,4-dihydroxy-α-Cyanocinnamate
|
|
132465-11-3 |
≥97%
|
|
|
2011-06-28
|
17.917223756906
|
cinnamyl-3-4-dihydroxy-cyanocinnamate
|
CDC
|
inhibitors 5-LO 5LO 12LO 15LO 5 LO 12 LO 15 LO 12-LO 15-LO LTB4 lipoxygenases immune responses inflammation
inhibits inhibition A23187 platelets shock assays |
17.917223756906
|
| 10120 |
CP 24,879 (hydrochloride)
|
|
10141-51-2 |
≥98%
|
|
|
|
7.046519337016
|
cp-24-879-hydrochloride
|
p-(Isopentyloxy)-aniline
|
.DELTA.5/.DELTA.6-desaturases inhibitors inhibits DELTA5/DELTA6-desaturases D5/D6-desaturases fatty acids hydrochlorides CP-24879 |
7.046519337016
|
| 10009291 |
Cysteinyl Leukotriene Express EIA Kit
|
|
- |
|
|
|
2008-08-11
|
254.400657960824
|
cysteinyl-leukotriene-express-eia-kit
|
CysLT Express ELISA Kit
|
solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs |
254.400657960824
|
| 10460 |
Doramapimod
|
|
285983-48-4 |
≥98%
|
|
|
2011-06-02
|
19.724613259668
|
doramapimod
|
BIRB-796
|
p38 MAPKs inflammation TNFα TNF-α TNF α TNFalpha TNF-alpha TNF alpha JNKs inhibitors proteins kinases tumors necrosis factors LPS THP.1 cells THP1 BIRB796 BIRB 796 mitogen activated mitogen-activated proinflammatory cytokins interleukin-1 IL IL-1 interleukin 1 |
19.724613259668
|
| 13151 |
(E)-C-HDMAPP (ammonium salt)
Exclusive
|
|
933030-60-5 |
≥95%
|
|
✓ |
2009-09-25
|
56.211049723757
|
-e-c-hdmapp-ammonium-salt
|
(E)-1-Hydroxy-2-Methylbut-2-enyl 4-Diphosphate (ammonium salt)
|
The pyrophosphonate form of (E)-HDMAPP; much more stable than (E)-HDMAPP in solution and in vascular circulation; potently stimulates the synthesis of TNF-α by γδ-T lymphocytes with an IC50 of 0.91 nM; also significantly increases the number of circulating γδ-T cells in vivo |
56.211049723757
|
| 9000295 |
Eicosapentaenoic Acid methyl ester
|
|
2734-47-6 |
≥98%
|
|
|
2011-10-07
|
53.386786372007
|
eicosapentaenoic-acid-methyl-ester
|
EPA methyl ester
|
vascular cardiovascular diseases immunity resolvins autoimmunity nephritis glomerulonephritis inflammation anti-inflammatory resolutions prodrugs antiinflammatory anti inflammatory immune physiology resolvins pro-drugs hydrolyzed esterases cells EPAs |
53.386786372007
|
| 600340 |
EP2 Receptor (rat) STEP Reporter Assay Kit (Luminescence)
Exclusive
|
|
- |
|
|
✓ |
2010-09-20
|
33.266108041743
|
ep2-receptor-rat-step-reporter-assay-kit-luminescence
|
Prostaglandin E2 Receptor 2; PGE2 Receptor 2
|
prostaglandins E2 PGE2 prostanoids G protein-coupled receptors GPCRs EP1 EP3 EP4 signal transduction tissues regulation cells mediates cAMP cyclic messenger pathways mucosal protection gastrointestinal secretions motility immunity inflammation mice mouse murine tumors cancers cancer-associated immunodeficiency dendritic-cell differentiation in vitro neuroprotective NMDA toxicity oxygen glucose deprivation agonists antagonists therapeutics Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening |
33.266108041743
|
| 600350 |
EP4 Receptor (rat) STEP Reporter Assay Kit (Luminescence)
|
|
- |
|
|
|
2010-11-04
|
27.996518460054
|
ep4-receptor-rat-step-reporter-assay-kit-luminescence
|
PGE2 Receptor 4; Prostaglandin E2 Receptor 4
|
prostaglandins E2 PGE2 prostanoids G protein-coupled receptors GPCRs EP1 EP2 EP3 signal transduction tissues regulation cells intestines lungs kidneys thymus brains uterus mediates cAMP cyclic messenger pathways PtdIns phosphatidylinositols 3-kinases Gi mediates relaxation smooth muscles gastric acid secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation mice mouse murine colon tumors cancers cancer-associated carcinogenesis in vivo neuroprotective NMDA neuroprotective excitotoxic brain injury agonists antagonists therapeutics Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening |
27.996518460054
|
| 10610 |
F-Amidine (trifluoroacetate salt)
Exclusive
|
|
- |
≥95%
|
|
✓ |
2011-09-23
|
28.482596685083
|
f-amidine-trifluoroacetate-salt
|
|
proteins arginine deiminase 4 PAD4 cancers arthritis inhibitors histones genes expression cysteine PAD1 PAD3 cytotoxic HL-60 MCF7 HT-29 877617-46-4 PADs PAD-1 PAD-3 PAD-4 peptidyl arginine |
28.482596685083
|
| 13563 |
FIPI
Exclusive
|
|
939055-18-2 |
≥98%
|
|
✓ |
2010-03-24
|
32.235558011049
|
fipi
|
5-Fluoro-2-Indolyl des-Chlorohalopemide
|
Phospholipases D PLD phosphatidic acids PA Ras activation cells spreading stress fiber formation chemotaxis membrane vesicles trafficking halopemide inhibitors inhibits inhibition PLD1 PLD2 F-actin cytoskeletons inflammation arthritis Pharmascience Brand of Domperidone Maleate
Stadapharm Brand of Domperidone Maleate
Ratiopharm Brand of Domperidone Maleate
Taxandria Brand of Domperidone Maleate
Novopharm Brand of Domperidone Maleate
Nu-Pharm Brand of Domperidone Maleate
Nu Pharm Brand of Domperidone Maleate
Apotex Brand of Domperidone Maleate
Hexal Brand of Domperidone Maleate
Aliud Brand of Domperidone Maleate
Teva Brand of Domperidone Maleate
Pierre Fabre Brand of Domperidone
Gry Brand of Domperidone Maleate
Rottapharm Brand of Domperidone
Monohydrochloride, Domperidone
Domperidone Monohydrochloride
Janssen Brand of Domperidone
Domperidone Maleate (1:1)
Maleate, Domperidone
Domperidone Maleate
Gamir Domperidona
Stada Domperidon
ratio-Domperidone
ratio Domperidone
Hexal Domperidon
Domperidona Gamir
Novo-Domperidone
Novo Domperidone
Domperidon Stada
Domperidon Hexal
PMS-Domperidone
PMS Domperidone Domperidon-TEVA Domperidon TEVA
Apo-Domperidone Apo Domperidone
Nu-Domperidone Nu Domperidone Domperidon AL Domperidone Gastrocure Domperidon R-33,812 Nauzelin Motilium R-33812 R33,812 Péridys Domidon R33812
|
32.235558011049
|
| 10007965 |
FK-506
|
|
104987-11-3 |
≥99%
|
|
|
2006-02-07
|
71.723847675922
|
fk-506
|
Tacrolimus
|
immunosuppressant immunosuppression inhibitor T cells activation cyclosporin A rapamycin Binding Proteins 12 FKBP12 calcium.calmodulin-dependent phosphatases calcineurins nitric oxides neurotoxicity neurotransmitter releases regulation Ca2+ Ca++ ryanodine inositols (1,4,5) triphosphates IP3 receptors fk506 |
71.723847675922
|
| 13739 |
FoxP3/Scurfin Polyclonal Antibody
|
|
- |
|
|
|
2010-01-18
|
0E-12
|
foxp3-scurfin-polyclonal-antibody
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC FoxP3 scurfins T cells T-cells Tregs diseases Immunology FOXP3-Scurfin |
0E-12
|
| 13744 |
FoxP3Δ2 (exon 2 deleted) Specific Monoclonal Antibody (Clone 16J4G6)
|
|
- |
|
|
|
2010-01-18
|
0E-12
|
foxp3-2-exon-2-deleted-specific-monoclonal-antibody-clone-16j4g6
|
|
antibodies western blots blotting immunoblotting WB FoxP3 scurfin T cells T-cells Tregs diseases delta Δ immunology .DELTA. |
0E-12
|
| 13743 |
FoxP3Δ2 (exon 2 deleted) Specific Monoclonal Antibody (Clone 16J4G6) (azide free)
|
|
- |
|
|
|
2010-01-18
|
0E-12
|
foxp3-2-exon-2-deleted-specific-monoclonal-antibody-clone-16j4g6-azide-free
|
|
antibodies western blots blotting immunoblotting WB FoxP3 scurfin T cells T-cells Tregs diseases delta Δ Immunology .DELTA. |
0E-12
|
| 10006292 |
FTY720
|
|
162359-56-0 |
≥98%
|
|
|
2005-02-09
|
227.489226519337
|
fty720
|
|
immune modulators sphingosine-1-phosphate receptors ISP1 S1P1 S1P5 S1P3 S1P4 ISP-1 myriocin kinases Abcc1 derivatives Iscaria sinclarii transplants transporter activity FTY 720 |
227.489226519337
|
| 13254 |
FTY720 phenoxy-biotin
Exclusive
|
|
- |
≥95%
|
|
✓ |
2009-10-28
|
71.479212707182
|
fty720-phenoxy-biotin
|
|
sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 biotins biotinylated biotinamide |
71.479212707182
|
| 10008639 |
FTY720 Phosphate
|
|
402615-91-2 |
≥98%
|
|
|
2007-04-26
|
114.414272559853
|
fty720-phosphate
|
FTY720P
|
agonist sphingosine-1-phosphate S1P transplants immunosuppression S1P1 S1P3 S1P4 S1P5 FTY720-P |
114.414272559853
|
| 10006407 |
FTY720 (R)-Phosphate
Exclusive
|
|
402616-23-3 |
≥98%
|
|
✓ |
2009-05-27
|
86.029359116022
|
fty720-r-phosphate
|
|
FTY720 sphingosines sphingosine-1-phosphates S1P S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 endothelial cells barrier functions immunosuppression FTY-720 FTY 720 |
86.029359116022
|
| 10006408 |
FTY720 (S)-Phosphate
|
|
402616-26-6 |
≥98%
|
|
|
2009-05-27
|
105.514176795580
|
fty720-s-phosphate
|
(S)-FTY 720P
|
FTY720 sphingosines sphingosine-1-phosphate S1P S1P1 S1P3 S1P4 S1P5 immunosuppression immune modulators Abcc1 Abcb1 transporters cPLA2 cytosolic phospholipase A2 endothelial cells barriers functions FTY720P |
105.514176795580
|
| 10008346 |
Gabapentin
|
|
60142-96-3 |
≥98%
|
|
|
2006-04-20
|
3.915138121546
|
gabapentin
|
Neurontin®
|
antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry |
3.915138121546
|
| 11512 |
HMGB1 Monoclonal Antibody (Clone IMG19N10B7)
New
|
|
- |
|
|
|
2012-01-16
|
0E-12
|
hmgb1-monoclonal-antibody-clone-img19n10b7
|
High Mobility Group Protein B1; HMG1
|
high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB |
0E-12
|
| 11513 |
HMGB1 Monoclonal Antibody (Clone IMG19N15F4)
New
|
|
- |
|
|
|
2012-01-16
|
0E-12
|
hmgb1-monoclonal-antibody-clone-img19n15f4
|
HMG1; High Mobility Group Protein B1
|
high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC
|
0E-12
|
| 11515 |
HMGB1 Polyclonal Antibody (aa 100-150)
New
|
|
- |
|
|
|
2012-01-20
|
0E-12
|
hmgb1-polyclonal-antibody-aa-100-150
|
HMG1; High Mobility Group Protein B1
|
high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC |
0E-12
|
| 500910 |
Human Therapeutic IgG1 EIA Kit
|
|
- |
|
|
|
2011-03-01
|
62.544723621493
|
human-therapeutic-igg1-eia-kit
|
Human IgG1 Immunometric EIA
|
drug discovery cytotoxicity toxicology non-human primates rhesus cynomolgus monkeys pharmacokinetics serum endogenous homology immunoglobulins species EIAs enzymes immunoassays kits measures measurements humans antibody antibodies IgG4 effectors Fc receptors leukocytes mediates antibody-induced cellular cells ADCC complement-mediated complements rodent plasma |
62.544723621493
|
| 500920 |
Human Therapeutic IgG4 EIA Kit
|
|
- |
|
|
|
2011-04-04
|
70.836160085581
|
human-therapeutic-igg4-eia-kit
|
Human IgG4 Immunometric ELISA
|
ELISA drug discovery cytotoxicity toxicology non-human primates rhesus cynomolgus monkeys pharmacokinetics serum endogenous homology immunoglobulins species EIAs enzymes immunoassays kits measures measurements humans antibody antibodies IgG1 effectors Fc receptors leukocytes mediates antibody-induced cellular cells ADCC complement-mediated complements rodent plasma |
70.836160085581
|
| 10809 |
Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B)
|
|
- |
|
|
|
2011-06-03
|
2.646408839779
|
interleukin-33-human-monoclonal-antibody-clone-il33305b
|
IL-1F11; IL-33; NF-HEV
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV |
2.646408839779
|
| 10811 |
Interleukin-33 Monoclonal Antibody (Clone IL33026B)
|
|
- |
|
|
|
2011-06-02
|
1.323204419889
|
interleukin-33-monoclonal-antibody-clone-il33026b
|
NF-HEV; IL-33; IL-1F11
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV |
1.323204419889
|
| 10810 |
Interleukin-33 Monoclonal Antibody (Clone IL333068A)
|
|
- |
|
|
|
2011-06-02
|
1.323204419889
|
interleukin-33-monoclonal-antibody-clone-il333068a
|
IL-33; NF-HEV; IL-1F11
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay 1F11 IL1F11 interleukin 33 NFHEV NF HEV |
1.323204419889
|
| 13925 |
IκBα (cleavage specific) Monoclonal Antibody (Clone 5D1623)
|
|
- |
|
|
|
2010-09-29
|
9.454917127071
|
i-b-cleavage-specific-monoclonal-antibody-clone-5d1623
|
|
antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular immunoblotting NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target cleaved caspases caspase-3 3 apoptosis amino-terminal amino terminals truncated DN-IκBα DNIκBα DN ΔN-IκBα ΔN .DELTA.N DELTAN .DELTA.N-IκBα DELTAN-IκBα DELTA-N .DELTA.-N degradation inducers dominant inhibitory molecule suppresses activity inflammation |
9.454917127071
|
| 13924 |
IκBα (Phospho-Ser32/36) Monoclonal Antibody - biotin (Clone 39A1413)
|
|
- |
|
|
|
2010-09-29
|
0E-12
|
i-b-phospho-ser32-36-monoclonal-antibody-biotin-clone-39a1413
|
|
antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser EIA ELISA biotins biotinylated inflammation genes regulation signal transduction |
0E-12
|
| 13923 |
IκBα (Phospho-Ser32/36) Monoclonal Antibody (Clone 39A1413)
|
|
- |
|
|
|
2010-09-29
|
12.893068809643
|
i-b-phospho-ser32-36-monoclonal-antibody-clone-39a1413
|
|
antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target immunoprecipitation IP serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser genes regulation inflammation signal transduction |
12.893068809643
|
| 10012659 |
Ki16425
|
|
355025-24-0 |
≥95%
|
|
|
2008-11-06
|
118.064818907305
|
ki16425
|
|
LPA1 LPA2 LPA3 LPA4 LPA5 lysophosphatidic acids cancers antagonist receptors selective |
118.064818907305
|
| 11208 |
KRN 7000
New
|
|
158021-47-7 |
≥98%
|
|
|
2012-03-30
|
41.476023391813
|
krn-7000
|
|
immunology cancers lupus diabetes malaria tuberculosis NKT cells GalCer α-galactosylceramide KRN7000 KRN-7000 AGL582 AGL 582 synthetic immune tumors autoimmune |
41.476023391813
|
| 11305 |
Kynurenine
New
|
|
2922-83-0 |
≥98%
|
|
|
2012-02-27
|
3.048518081679
|
kynurenine
|
3-anthraniloyl-Alanine
|
typtophan pathways catabolism glioma typtophan-2,3-dioxygenase tumors AhR aryl hydrocarbons receptors quinolinic acid neurodegenerative diseases L-Kynurenine 3-anthraniloyl-alanine kynurenin |
3.048518081679
|
| 10007817 |
Leukotriene A4 Hydrolase (human recombinant)
|
|
- |
≥90%
|
|
|
2005-12-14
|
275.808100344092
|
leukotriene-a4-hydrolase-human-recombinant
|
LTA4H
|
leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis active |
275.808100344092
|
| 160250 |
Leukotriene A4 Hydrolase Polyclonal Antibody
|
|
- |
|
|
|
|
187.400510726632
|
leukotriene-a4-hydrolase-polyclonal-antibody
|
LTA4 Hydrolase
|
LTA4 leukotrienes LTB4 5-lipoxygenases antibodies 5-LOS western blots blotting WB antisera antiserum hydrolases immunoblotting |
187.400510726632
|
| 20110 |
Leukotriene B4
|
|
71160-24-2 |
≥97%
|
|
|
|
180.943799155021
|
leukotriene-b4
|
LTB4
|
leukotrienes LTB4 inflammation chemotaxis atherosclerosis |
180.943799155021
|
| 20114 |
Leukotriene B4-3-aminopropylamide
|
|
89596-43-0 |
≥95%
|
|
|
2009-03-05
|
429.324088397790
|
leukotriene-b4-3-aminopropylamide
|
LTB4-3-aminopropylamide
|
LTB LTB4 BLTs BLT1 BLT2 inflammation immunology |
429.324088397790
|
| 520111 |
Leukotriene B4 EIA Kit
|
|
- |
|
|
|
|
1106.047323511356
|
leukotriene-b4-eia-kit
|
Leukotriene B4 ELISA Kit
|
solid plates neutrophils 5-LOs 5-lipoxygenases LTB4 measures kits atherosclerosis eias enzyme immunoassays ELISAs leukotrienes assays |
1106.047323511356
|
| 10007240 |
Leukotriene B4 Lipid Maps MS Standard
|
|
71160-24-2 |
≥97%
|
|
|
2009-01-14
|
29.751524861878
|
leukotriene-b4-lipid-maps-ms-standard
|
LTB4
|
leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards |
29.751524861878
|
| 10011453 |
Lipoxin A5
Exclusive
|
|
110657-98-2 |
≥95%
|
|
✓ |
2008-11-17
|
52.935755064456
|
lipoxin-a5
|
LXA5
|
EPAs LXA4 LXB4 smooth muscle contraction lipoxins vasodilatory leukocytes pulmonary parenchymal LXAs |
52.935755064456
|
| 10010785 |
(±)-Lisofylline
|
|
6493-06-7 |
≥98%
|
|
|
2009-09-18
|
21.729350828728
|
-lisofylline
|
CT-1501R; BL 194; LSF
|
pentoxifylline phosphatidic acids shock sepsis antiinflammatory anti-inflammatory insulin diabetes IL-12 IL-12 inhibits inhibitions inhibitors IFN-γ IFNγ β-cell cell 39476-38-5 151852-35-3 |
21.729350828728
|
| 10006984 |
LPA1 Blocking Peptide
|
|
- |
|
|
|
2006-03-16
|
29.845082872929
|
lpa1-blocking-peptide
|
Vzg-1; LPAR1; LPA Receptor 1; EDG-2
|
proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry analogs GPCRs controls |
29.845082872929
|
| 10005280 |
LPA1 Polyclonal Antibody
|
|
- |
|
|
|
2005-04-05
|
51.540705954573
|
lpa1-polyclonal-antibody
|
EDG-2; Vzg-1; LPAR1; LPA Receptor 1
|
LPA analogs antibodies antisera antiserum western blots blotting wb icc immunocytochemistry GPCRs immunoblotting |
51.540705954573
|
| 10005092 |
LPA3 Blocking Peptide
|
|
- |
|
|
|
2004-05-11
|
54.346721915285
|
lpa3-blocking-peptide
|
Lysophosphatidic Acid Receptor 3; EDG-7
|
LPA analogs antibodies western blots blotting wb icc immunocytochemistry control peptides |
54.346721915285
|
| 10004840 |
LPA3 Polyclonal Antibody
|
|
- |
|
|
|
2004-05-11
|
32.381704814522
|
lpa3-polyclonal-antibody
|
EDG-7; Lysophosphatidic Acid Receptor 3
|
analogs antibodies antisera antiserum western blots blotting wb icc immunocytochemistry GPCRs edg7 receptors g-proteins coupled s1p1-5 cellular responses, cytoskeletal rearrangements proliferation inhibits inhibitors inhibition gap junction communication immunoblotting ELISA |
32.381704814522
|
| 10010024 |
LY223982
Exclusive
|
|
117423-74-2 |
≥98%
|
|
✓ |
2008-07-24
|
2.106629834254
|
ly223982
|
SKF 107324; CGS 23131
|
LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis leukotriene B4 fatty acids 5-LO 5LO CGS23131 SKF107234 |
2.106629834254
|
| 10009768 |
LY293111
Exclusive
|
|
161172-51-6 |
≥98%
|
|
✓ |
2009-02-09
|
62.413743093923
|
ly293111
|
Etalocib; VML 295
|
LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers |
62.413743093923
|
| 13848 |
MEKK2 Polyclonal Antibody
|
|
- |
|
|
|
2010-12-21
|
0E-12
|
mekk2-polyclonal-antibody
|
MAP Kinase/ERK Kinase Kinase 2; Dual Specificity MAP Kinase Kinase Kinase 2; MAP Kinase Kinase Kinase 2; MAP3K2; MAPKKK2
|
MEKs MEK-2 MEK 2 MAPKs kinases MAPs mitogen-activated mitogen activated proteins signaling pathway phosphorylate IkB I.kappa.B IkappaB IκB NF-κB NF-kappaB NF-.kappa.B NFκB NF.kappa.B NFkB T-cells T cells cytokine genes expressions mast cells epidermal growth factor EGRs fibroblast growth factor-2 factor 2 FGF-2 FGF2 FGFs 2 signals rheumatoid arthritis LPS-TLR4 LPS TLR4 TLR-4 TLR 4 ligands phosphorylation western blots blotting immunoblotting WB immunohistochemistry IHC MAP kinase kinase kinase |
0E-12
|
| 600160 |
Methionine Sulfoxide Immunoblotting Kit
|
|
- |
|
|
|
2009-12-17
|
234.812994475138
|
methionine-sulfoxide-immunoblotting-kit
|
MetO Immunoblotting Kit
|
proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 |
234.812994475138
|
| 10010252 |
Methyl-L-NIO (hydrochloride)
|
|
150403-96-6 |
>98%
|
|
|
2008-02-12
|
15.730469613259
|
methyl-l-nio-hydrochloride
|
|
NOS L-arginine NO nitric oxide nNOS eNOS iNOS inhibitor inhibits inhibition vasodilation inflammation |
15.730469613259
|
| 11189 |
N-acetyl-Pro-Gly-Pro Peptide
New
|
|
- |
≥95% by HPLC
|
|
|
2012-02-02
|
32.668493069690
|
n-acetyl-pro-gly-pro-peptide
|
N-acetyl-PGP
|
chemokines receptors ligands COPD cystic fibrosis neutrophils infiltration PMN chemoattractants CXC ECM PGP metabolites BAL bronchoalveolar inflammation inflammatory diseases |
32.668493069690
|
| 16841 |
NBD-FTY720 phenoxy (hydrochloride)
|
|
- |
≥96%
|
|
|
2009-08-04
|
75.104069981583
|
nbd-fty720-phenoxy-hydrochloride
|
|
sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 fluorescent fluorescence FTY720-phosphates sphingosines immunosuppression immune modulators transporters cPLA2 cytosolic phospholipases A2 phosphorylation |
75.104069981583
|
| 13755 |
NF-κB (p50) Monoclonal Antibody (Clone 2J10D7)
|
|
- |
|
|
|
2010-02-05
|
12.341988950276
|
nf-b-p50-monoclonal-antibody-clone-2j10d7
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry |
12.341988950276
|
| 13756 |
NF-κB (p65) Monoclonal Antibody-biotin (Clone 112A1021)
|
|
- |
|
|
|
2010-02-11
|
20.124822415153
|
nf-b-p65-monoclonal-antibody-biotin-clone-112a1021
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones |
20.124822415153
|
| 13752 |
NF-κB (p65) Monoclonal Antibody (Clone 112A1021)
|
|
- |
|
|
|
2010-02-11
|
20.313535911601
|
nf-b-p65-monoclonal-antibody-clone-112a1021
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC |
20.313535911601
|
| 13751 |
NF-κB (p65) NLS Polyclonal Antibody
|
|
- |
|
|
|
2010-02-11
|
20.545580110496
|
nf-b-p65-nls-polyclonal-antibody
|
Nuclear Factor-κB (p65) Nuclear Localization Signal
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies |
20.545580110496
|
| 13757 |
NF-κB (p65) Polyclonal Antibody (aa 2-17)
|
|
- |
|
|
|
2010-02-11
|
14.566101026045
|
nf-b-p65-polyclonal-antibody-aa-2-17
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 |
14.566101026045
|
| 13753 |
NF-κB (p65) Polyclonal Antibody (aa 538-546)
|
|
- |
|
|
|
2010-02-11
|
19.484806629834
|
nf-b-p65-polyclonal-antibody-aa-538-546
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 |
19.484806629834
|
| 13390 |
N-methyl Leukotriene C4
|
|
131391-65-6 |
>97%
|
|
|
2008-10-15
|
85.482108655616
|
n-methyl-leukotriene-c4
|
N-methyl LTC4
|
allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics |
85.482108655616
|
| 10004942 |
Nod2 Monoclonal Antibody (Clone 2D9)
|
|
- |
|
|
|
2004-09-08
|
8.118306931246
|
nod2-monoclonal-antibody-clone-2d9
|
|
antisera antibody antibodies nod1 apoptosis nf kb nf-kb nf-.kappa.b nf-kappab crohn's diseases inflammations inflammatory bowel nod-2 nod-1 antiserum apoptosis caspases CARDs western blots blotting WB immunohistochemical immunohistochemistry IHC nfkb immunoblotting |
8.118306931246
|
| 160777 |
Nod2 Polyclonal Antibody
|
|
- |
|
|
|
|
8.901795449601
|
nod2-polyclonal-antibody
|
|
antisera antibody antibodies nod1 apoptosis nf-kb nf-.kappa.b nf-kappab crohn's disease inflammation inflammatory bowel nod-2 nod-1 antiserum WB western blots blotting immunoblotting IP immunoprecipitation |
8.901795449601
|
| 11040 |
Nodinitib-1
New
|
|
799264-47-4 |
≥95%
|
|
|
2012-01-20
|
11.548480010440
|
nodinitib-1
|
ML130; CID-1088438
|
NOD1 NLR innate immunity NF-κB signaling inflammation MAPK inflammatory diseases inhibitors inhibition inhibits NACHT leucine proteins bacterial bacteria ligands stress kinases interferons polymorphisms genes asthma bowel multiple sclerosis MS cells CD83 CD86 HLA-DR IL-1β IL-6 TNFα |
11.548480010440
|
| 90510 |
O-11
|
|
119290-12-9 |
>98%
|
|
|
2004-07-06
|
37.960819521178
|
o-11
|
11-Oxatetradecanoic Acid
|
myristic acids Trypanosoma brucei parasites protozoans African sleeping sickness Trypanosine inhibitors trypansomes 10-propoxydecanoic variant surface glycoproteins toxic myristate vsg |
37.960819521178
|
| 500930 |
PAD4 Autoantibody EIA Kit
|
|
- |
|
|
|
2011-08-18
|
16.738756906077
|
pad4-autoantibody-eia-kit
|
Protein Arginine Deiminase 4; Peptidylartginine Deaminase 4
|
peptidylarginine deiminase proteins arginines deiminases 4 guanidine guanidino-modifying enzymes amidinotransferases superfamily homodimers transcriptional coregulators catalyzes residues citrulline calcium-dependent rheumatoid arthritis RA arthritogenic autoantibodies citrullinated peptides cyclics CCP anti-CCP immunoassays immunometrics assays kits measures measurement isotypes IgM IgG IgA human plasmas serums |
16.738756906077
|
| 10500 |
PAD4 (human recombinant)
|
|
- |
≥95%
|
|
|
2010-05-27
|
68.342983425414
|
pad4-human-recombinant
|
Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4
|
guanidino modifying enzymes citrillination histones deiminase MS multiple sclerosis Alzheimer's diseases glaucoma IOP intraocular pressure cancers peptidylarginine deiminase active |
68.342983425414
|
| 500290 |
Phagocytosis Assay Kit (IgG FITC)
|
|
- |
|
|
|
2009-04-09
|
143.746594904470
|
phagocytosis-assay-kit-igg-fitc
|
|
kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba |
143.746594904470
|
| 600540 |
Phagocytosis Assay Kit (IgG PE)
New
|
|
- |
|
|
|
2012-01-10
|
108.089974089607
|
phagocytosis-assay-kit-igg-pe
|
|
kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba phycoerythrins probes fluorescence |
108.089974089607
|
| 10011332 |
Plerixafor (hydrochloride hydrate)
|
|
155148-31-5 |
≥98%
|
|
|
2009-02-10
|
177.592850828729
|
plerixafor-hydrochloride-hydrate
|
Mobozil™; SID 791; JM 3100; AMD 3100
|
stem cells hematopoiesis HIV lymphocyte replication metastasis cancers growth antagonist CXCR4 SDF-1 SDF1 CXCL12 ireversible virus inhibits inhibition inhibitor |
177.592850828729
|
| 11004 |
Podoplanin Monoclonal Antibody (Clone NZ-1.2)
|
|
- |
|
|
|
2011-08-05
|
0E-12
|
podoplanin-monoclonal-antibody-clone-nz-1-2
|
Aggrus; gp38; T1A
|
mucin glycoproteins T1A gp38 aggrus tumors cells ligands CLEC-2 metastases tissues Th17 CD4+ humans PBMC antibodies |
0E-12
|
| 11005 |
Podoplanin Monoclonal Antibody (Clone pmab-1)
|
|
- |
|
|
|
2011-08-05
|
0E-12
|
podoplanin-monoclonal-antibody-clone-pmab-1
|
gp38; Aggrus; T1A
|
gp38 glycoproteins tissues lymphatic endothelial cells tumors lymphangiogenesis Th17 autoimmune diseases antibodies myelin antigens migration inflammation |
0E-12
|
| 13327 |
PPM-18
|
|
65240-86-0 |
≥95%
|
|
|
2010-09-15
|
9.159502762431
|
ppm-18
|
NSC 73233
|
inhibitors inhibits inhibition NF-κB NFκB NF κB NF-kB NFkB kB iNOS inflammation sepsis inducible nitric oxides synthases inflammatory NO Naphthalenediones
Naphthoquinones
Naphthazarins |
9.159502762431
|
| 11188 |
Prolyl-glycyl-proline Peptide
New
|
|
- |
≥95% by HPLC
|
|
|
2012-02-02
|
32.868001841620
|
prolyl-glycyl-proline-peptide
|
PGP
|
LTA4 hydrolases substrates COPD cystic fibrosis neutrophils infiltration CF MMP-8 MMP-9 CXCR1 CXCR2 chemoattractants |
32.868001841620
|
| 10011724 |
Propenyl-L-NIO (hydrochloride)
Exclusive
|
|
- |
≥90%
|
|
✓ |
2008-08-19
|
8.798936464088
|
propenyl-l-nio-hydrochloride
|
ENIPO
|
nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition |
8.798936464088
|
| 14010 |
Prostaglandin E2
|
|
363-24-6 |
≥99%
|
|
|
|
254.887908687252
|
prostaglandin-e2
|
PGE2; Dinoprostone
|
PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 |
254.887908687252
|
| 514018 |
Prostaglandin E2 Affinity Purification Kit (20 ml)
|
|
- |
|
|
|
|
255.212386740331
|
prostaglandin-e2-affinity-purification-kit-20-ml
|
PGE2 Affinity Purification Kit
|
PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies |
255.212386740331
|
| 500450 |
Prostaglandin E2 Affinity Purification Kit (4 ml)
|
|
- |
|
|
|
2010-07-28
|
199.876045777427
|
prostaglandin-e2-affinity-purification-kit-4-ml
|
PGE2
|
PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies |
199.876045777427
|
| 10581 |
Prostaglandin E2-d9
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
|
2010-09-16
|
96.365778084715
|
prostaglandin-e2-d9
|
PGE2-d9; Dinoprostone-d9
|
PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards |
96.365778084715
|
| 514010 |
Prostaglandin E2 EIA Kit - Monoclonal
|
|
- |
|
|
|
|
1871.181459902895
|
prostaglandin-e2-eia-kit-monoclonal
|
PGE2 EIA Kit - Monoclonal; Prostaglandin E2 ELISA Kit - Monoclonal
|
solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs assays PGE2 |
1871.181459902895
|
| 500141 |
Prostaglandin E2 Express EIA Kit
|
|
- |
|
|
|
|
508.996737569060
|
prostaglandin-e2-express-eia-kit
|
PGE2 Express EIA Kit; Prostaglandin E2 Express ELISA Kit
|
solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs same-day assays |
508.996737569060
|
| 500501 |
Prostaglandin E2 FPIA Kit - Green
|
|
- |
|
|
|
|
153.291009821976
|
prostaglandin-e2-fpia-kit-green
|
PGE2 Fluorescence Polarization Immunoassay - Green
|
kitrecommendation:pge2 metabolites EP1 EP2 EP3 EP4 prostaglandins immunoassays HTS fluorescent high-throughput kits screenings fluorescence fluorometric assays |
153.291009821976
|
| 10384 |
Prostaglandin E2 isopropyl ester
Exclusive
|
|
71845-66-4 |
≥98%
|
|
✓ |
2010-06-07
|
344.740252565114
|
prostaglandin-e2-isopropyl-ester
|
|
PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic |
344.740252565114
|
| 10007211 |
Prostaglandin E2 Lipid Maps MS Standard
|
|
363-24-6 |
>99%
|
|
|
2008-11-05
|
17.902946593001
|
prostaglandin-e2-lipid-maps-ms-standard
|
Dinoprostone; PGE2
|
PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS |
17.902946593001
|
| 10272 |
Prostratin
|
|
60857-08-1 |
≥98%
|
|
|
2009-06-11
|
34.766055248618
|
prostratin
|
SA 101A; NSC 623310; 13-O-Acetylphorbol
|
HIV-1 AIDS NF-κB PKC T cells CD4 CXCR4 CCR5 stillingia factor S7 SFS7 13-O-acetyl-12-deoxy phorbol |
34.766055248618
|
| 13294 |
Pyrrophenone
|
|
341973-06-6 |
≥90%
|
|
|
2010-04-07
|
48.304680347276
|
pyrrophenone
|
|
phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory Pyrrolidines |
48.304680347276
|
| 13346 |
Rapamycin
|
|
53123-88-9 |
≥95%
|
|
|
2009-10-21
|
44.025417638632
|
rapamycin
|
Sirolimus
|
immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases |
44.025417638632
|
| 10012554 |
Resolvin D1
Exclusive
|
|
872993-05-0 |
≥95%
|
|
✓ |
2008-06-06
|
256.332392917195
|
resolvin-d1
|
RvD1; 17(S)-Resolvin D1
|
EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 |
256.332392917195
|
| 10007279 |
Resolvin D2
Exclusive
|
|
810668-37-2 |
≥95%
|
|
✓ |
2010-06-25
|
140.031152498541
|
resolvin-d2
|
7(S),16(R),17(S)-Resolvin D2
|
EPA DHA inflammation anti-inflammatory antiinflammatory immune responses sepsis Docosahexaenoic Acid 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-(All-Z-Isomer)
Docosahexaenoic Acid 4,7,10,13,16,19-Isomer
Docosahexaenoic Acid 3,6,9,12,15,18-Isomer
Docosahexaenoic Acid Dimer (All-Z Isomer)
Docosahexaenoic Acid (All-Z Isomer) Acids Docosahexaenoic
Docosahexaenoic Acids
Acids Docosahexenoic
Docosahexenoic Acids
Docosahexaenoic Acid
Docosahexaenoate 10007848
|
140.031152498541
|
| 11017 |
Retinoic Acid
|
|
302-79-4 |
≥98%
|
|
|
2011-10-25
|
17.543287906690
|
retinoic-acid
|
ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578
|
ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans |
17.543287906690
|
| 11002 |
Retinoid-Related Orphan Receptor γ Monoclonal Antibody (Clone 4G419)
|
|
- |
|
|
|
2011-08-09
|
23.618150194393
|
retinoid-related-orphan-receptor-monoclonal-antibody-clone-4g419
|
RAR-Related Orphan Receptor; ROR-γ; NR1F3
|
antibodies receptors DNA gamma amino acids transcription factors ROR proteins ligands Fas IL2 RORA RORB tissues muscles lymph nodes cells Nuclear Receptor RZR gamma Nuclear receptor RZR-gamma Nuclear Receptor RZR-gamma Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor gamma Retinoid-related orphan receptor-gamma Retinoid-Related Orphan Receptor-gamma RZR gamma RZR-gamma, Nuclear Receptor nuclear receptor ROR-gamma retinoic acid receptor-related orphan receptor gamma RORgamma |
23.618150194393
|
| 11003 |
Retinoid-Related Orphan Receptor γ Polyclonal Antibody
|
|
- |
|
|
|
2011-08-09
|
23.618150194393
|
retinoid-related-orphan-receptor-polyclonal-antibody
|
RAR-Related Orphan Receptor γ; NR1F3; ROR-γ
|
antibodies receptors DNA gamma amino acids transcription factors ROR proteins ligands Fas IL2 RORA RORB tissues muscles lymph nodes cells RAR Nuclear Receptor RZR gamma Nuclear receptor RZR-gamma Nuclear Receptor RZR-gamma Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor gamma Retinoid-related orphan receptor-gamma Retinoid-Related Orphan Receptor-gamma RZR gamma RZR-gamma, Nuclear Receptor nuclear receptor ROR-gamma retinoic acid receptor-related orphan receptor gamma RORgamma |
23.618150194393
|
| 13616 |
(R)-Lisofylline
|
|
100324-81-0 |
≥98%
|
|
|
2010-05-27
|
1.331906077348
|
-r-lisofylline
|
(R)-LSF; (-)-Lisofylline
|
pentoxifylline phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes interleukins 12 IL IFN-gamma |
1.331906077348
|
| 10011132 |
Rolipram
|
|
61413-54-5 |
≥98%
|
|
|
2008-12-16
|
11.059300184162
|
rolipram
|
ZK 62711; SB 95952
|
inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss |
11.059300184162
|
| 10006616 |
S1P1 Blocking Peptide
|
|
- |
|
|
|
2005-03-02
|
49.768934490923
|
s1p1-blocking-peptide
|
Sphingosine-1-phosphate Receptor 1; S1PR1; EDG-1
|
antibodies western blotting blots signaling signalling WB IHC ICC immunohistochemistry formalin-fixed paraffin-embedded sections immunocytochemistry receptors controls peptides proteins sphingosine-1-phosphate receptors G-protein-coupled S1P1/EDG-1 S1P2/EDG-5 S1P3/EDG-3 S1P4/EDG-6 S1P5/EDG-8 |
49.768934490923
|
| 10005228 |
S1P1 Polyclonal Antibody
|
|
- |
|
|
|
2005-02-09
|
51.358497237568
|
s1p1-polyclonal-antibody
|
EDG-1; S1PR1; Sphingosine-1-phosphate Receptor 1
|
antisera antiserum antibodies proteins WB western blots blotting IHC ICC immunohistochemistry immunocytochemistry sphingosine-1-phosphate receptors G-protein-coupled S1P1/EDG-1 S1P2/EDG-5 S1P3/EDG-3 S1P4/EDG-6 S1P5/EDG-8 immunoblotting |
51.358497237568
|
| 13488 |
S1P2 Polyclonal Antibody
|
|
- |
|
|
|
2009-08-24
|
35.524585635358
|
s1p2-polyclonal-antibody
|
Sphingosine-1-phosphate Receptor 2; S1PR2; EDG-5
|
Western blots WB immunoblotting lysosphingolipid sphingosine 1-phosphate cells PTEN blotting EDG-5 EDG5 EDG 5 |
35.524585635358
|
| 10006373 |
S1P3 Polyclonal Antibody
|
|
- |
|
|
|
2005-08-23
|
47.482995702885
|
s1p3-polyclonal-antibody
|
Sphingosine-1-phosphate Receptor 3; S1PR3; EDG-3
|
antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry FACS flow cytometry sphingosine-1-phosphates GPCRs G-protein-coupled receptors S1P1 S1P2 S1P4 S1P5 edg-1 edg-5 edg-6 edg-8 couples coupling Gi/o-ERK G12/13-Rho axes mediates cell proliferation survival migration singalling events expressed tissues physiological functions receptors human mouse murine glycosylation N-terminal extracellular domains proteins migrates SDS-PAGE cerbral cortex liver heart immunoblotting |
47.482995702885
|
| 13489 |
S1P4 Polyclonal Antibody
|
|
- |
|
|
|
2009-08-25
|
13.423839779005
|
s1p4-polyclonal-antibody
|
Sphingosine-1-phosphate Receptor 4; S1PR4; EDG-6
|
Flow immunoblotting WB western blots immunoblotting ICC immunocytochemistry blotting |
13.423839779005
|
| 13490 |
S1P5 Polyclonal Antibody
|
|
- |
|
|
|
2009-08-24
|
14.551832412522
|
s1p5-polyclonal-antibody
|
EDG-8; S1PR5; Sphingosine-1-phosphate Receptor 5
|
Western blots WB immunoblotting S1P immunohistochemistry IHC paraffin blotting EDG-8 EDG8 EDG 8 |
14.551832412522
|
| 10006440 |
SEW2871
|
|
256414-75-2 |
>98%
|
|
|
2005-03-09
|
81.383655616943
|
sew2871
|
|
FTY720 sphingosines 1-phosphates receptor-1 S1P1 agonists immunosuppression brandycardia G-proteins receptors lymphocytes recirculation blood heart rate GPR FTY 720 sew 2871 |
81.383655616943
|
| 13617 |
(S)-Lisofylline
Exclusive
|
|
100324-80-9 |
≥98%
|
|
✓ |
2010-05-27
|
1.174447513812
|
-s-lisofylline
|
(S)-LSF; (+)-Lisofylline
|
pentoxifyllines phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes antiinflammatory inflammatory inflammation inflammed |
1.174447513812
|
| 10006964 |
Sphingomyelinase Assay Kit
|
|
- |
|
|
|
2009-11-25
|
79.522564712502
|
sphingomyelinase-assay-kit
|
SMase Assay Kit
|
sphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNases I superfamily sphingomyelins phosphorylcholines ceramides cells cellular stress cations lysosomal acids secreted zinc-dependent membrane-bound magnesium-dependent neutral cytosolic magnesium-independent neutral alkalines mutations ASM genes Type A B Niemann-Pick diseases physiological pathophysiological lysosomal digestion neuronal vascular ceramide-mediated signal transduction cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessel walls atherogenesis intracellular trafficking metabolism assays kits measures measuring measurements acidic activity tissues homogenates lysates serum blood saliva urine coupled enzymatic reactions oxidases betaine h2o2 hydrogen peroxides horseradish peroxidases HRPs 10-acetyl-3,7-dihydroxyphenozazine ADHP fluorescent fluorescence |
79.522564712502
|
| 62570 |
Sphingosine-1-Phosphate
|
|
26993-30-6 |
≥98%
|
|
|
|
130.741114497999
|
sphingosine-1-phosphate
|
S1P; Sphingosine-1-Phosphoric Acid
|
sphingosines phosphates ceramides apoptosis Sphingosine-1-phosphoric acids cells death kinases sphingomyelin growth calcium |
130.741114497999
|
| 10006822 |
Sphingosine Kinase 1 Polyclonal Antibody
|
|
- |
|
|
|
2006-12-21
|
23.619964088397
|
sphingosine-kinase-1-polyclonal-antibody
|
SPHK 1
|
proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry sphingosines kinases enzymes sphingolipids metabolisms catalyzes phosphorylation sphingosine-1-phosphates cells proliferation death tissues kidneys livers spleen hearts platelets tumors cytosolic membranes amino acids post translational modifications SK1 SPK1 cancers immunoblotting |
23.619964088397
|
| 10009222 |
Sphingosine Kinase Inhibitor 2
|
|
312636-16-1 |
≥95%
|
|
|
2007-01-18
|
33.660262430938
|
sphingosine-kinase-inhibitor-2
|
SKI II; SPHK 2
|
cancers Anti-proliferative Sphingosine-1-phosphates S1Ps SK1 SK2 SKI2 SPHK1 SPHK2 sphingosines sphingolipids inhibits inhibitors inhibition proliferation |
33.660262430938
|
| 10922 |
SR 1001
|
|
- |
≥98%
|
|
|
2011-06-28
|
59.075591160220
|
sr-1001
|
|
inflammation autoimmune diseases RORα RORγ retinoic-acid-receptor-related orphans receptors IL-17 TH17 cells ligands mutiple sclerosis MS agonists differentiation PBMCs inhibits inhibitors inhibition splenocytes NCoR SR1001 SR-1001 |
59.075591160220
|
| 9000491 |
SR 144528
|
|
192703-06-3 |
≥98%
|
|
|
2009-08-05
|
72.405013812154
|
sr-144528
|
|
antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic |
72.405013812154
|
| 11444 |
T-2 Toxin
New
|
|
21259-20-1 |
≥98%
|
|
|
2012-05-01
|
73.476923076922
|
t-2-toxin
|
NSC 138780; Mycotoxin T-2; Fusariotoxin T-2; Insariotoxin
|
9061-58-9 11051-21-1 22916-10-5 22916-18-3 25152-34-5 26400-47-5 27640-92-2 36653-66-4 60119-99-5 116163-69-0 145427-93-6 NSC-138780 NSC138780 T2 mycotoxin Toxin T2 trichothecene mycotoxins aleukia Toxin T2 inhibitors inhibits inhibition proteins synthesis cytotoxic macrophages inflammation immune responses immunosuppression Fusarium grains ribotoxic JNK/p38 MAPKs metabolism membranes phospholipids livers apoptosis mediators IL-1β TNFα nitric oxide TLR4 TLR2/6 agonists |
73.476923076922
|
| 13585 |
Toll-Like Receptor 11 Polyclonal Antibody
|
|
- |
|
|
|
2009-11-12
|
0.484466638334
|
toll-like-receptor-11-polyclonal-antibody
|
TLR11
|
antibodies toll like TLRs western blotting blots immunoblotting WB intracellular flow cytometry FC bacterias kidneys interinal organs |
0.484466638334
|
| 13586 |
Toll-Like Receptor 12 Polyclonal Antibody
|
|
- |
|
|
|
2009-11-23
|
0.484466638334
|
toll-like-receptor-12-polyclonal-antibody
|
TLR12
|
antibodies toll like TLRs western blots blotting immunoblotting WB FC flow cytometry macrophages liver kidney bladder epithelial cells intracellular |
0.484466638334
|
| 13582 |
Toll-Like Receptor 1 Polyclonal Antibody
|
|
- |
|
|
|
2009-10-10
|
1.500361240969
|
toll-like-receptor-1-polyclonal-antibody
|
TLR1
|
antibodies toll like TLRs receptor-1 receptors mammals transmembrane proteins leucine WB western blots blotting immunoblotting flow intracellular cells surface TLR2 lipids lipoproteins |
1.500361240969
|
| 13588 |
Toll-Like Receptor 3 Monoclonal Antibody (Clone 40C1285.6)
|
|
- |
|
|
|
2009-10-27
|
0.484466638334
|
toll-like-receptor-3-monoclonal-antibody-clone-40c1285-6
|
TLR3
|
toll like TLRs receptors western blot WB blotting immunoblotting flow cytometry FC intracellular cell surface immunoprecipitation IP immunohistochemisty IHC immunocytochemistry ICC immunofluorescence IF interleukin-1 IL-1 antibodies |
0.484466638334
|
| 13589 |
Toll-Like Receptor 4 Monoclonal Antibody (Clone HTA125)
|
|
- |
|
|
|
2009-10-27
|
0.484466638334
|
toll-like-receptor-4-monoclonal-antibody-clone-hta125
|
TLR4
|
antibodies toll like receptors flow cytometry FC intracellular cell surface immunoprecipitation IP FA neutralization immunofluorescence immunocytochemistry IF ICC confocal microscopy TLRs immunoblotting blotting |
0.484466638334
|
| 13595 |
Toll-Like Receptor 5 Monoclonal Antibody (Clone 85B152.5)
|
|
- |
|
|
|
2009-10-27
|
0.484466638334
|
toll-like-receptor-5-monoclonal-antibody-clone-85b152-5
|
TLR5
|
antibodies WB FC intracellular cells surface TLRs western blotting blots immunoblotting flow cytometry |
0.484466638334
|
| 13591 |
Toll-Like Receptor 7 Polyclonal Antibody
|
|
- |
|
|
|
2009-11-23
|
0.484466638334
|
toll-like-receptor-7-polyclonal-antibody
|
TLR7
|
receptors tolls like antibodies TLRs western blots blotting immunoblotting WB flow cytometry FC intracellular cells surface immunohistochemistry IHC frozen paraffin-embedded sections paraffin embedded immunocytochemistry ICC immunoprecipitation IP TLR7 TLR 7 |
0.484466638334
|
| 13592 |
Toll-Like Receptor 8 Monoclonal Antibody (Clone 44C143)
|
|
- |
|
|
|
2009-11-09
|
0.484466638334
|
toll-like-receptor-8-monoclonal-antibody-clone-44c143
|
TLR8
|
antibodies blotting immunoblotting WB western blots IHC immunohistochemistry flow cytometry FC intracellular cells surface paraffin embedded sections paraffin-embedded exons cDNATLRs TLR-8 TLR 8 |
0.484466638334
|
| 13593 |
Toll-Like Receptor 9 Monoclonal Antibody (Clone 26C593.2)
|
|
- |
|
|
|
2009-11-09
|
2.579239269018
|
toll-like-receptor-9-monoclonal-antibody-clone-26c593-2
|
TLR9
|
antibodies western blots blotting immunoblotting tolls like bacterial DNA confocal microscopy flow cytometry FC intracellular cell surface immunohistochemistry IHC frozen paraffin-embedded sections paraffin embedded immunofluorscence IF immunocytometry ICC |
2.579239269018
|
| 13044 |
Tranilast
|
|
53902-12-8 |
≥98%
|
|
|
2008-08-29
|
71.116731123388
|
tranilast
|
SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid
|
anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF |
71.116731123388
|
| 70740 |
U-73122
|
|
112648-68-7 |
≥97%
|
|
|
|
48.615801104973
|
u-73122
|
|
inhibitors inhibits PLC phospholipases C HIV-1 integrase u73122 |
48.615801104973
|
| 10812 |
Vaspin (human) Monoclonal Antibody (Clone VP63)
|
|
- |
|
|
|
2011-06-27
|
1.933011049723
|
vaspin-human-monoclonal-antibody-clone-vp63
|
OL-64; Visceral Adipose Tissue-Derived Serine Protease Inhibitor; Serpin A12
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay serpin adipocytokine immune response inflammation obesity insulin |
1.933011049723
|
| 11791 |
Vitamin D2
New
|
|
50-14-6 |
≥98%
|
|
|
2012-05-24
|
148.659649122807
|
vitamin-d2
|
Infron; Uvesterol D; Davitamon D; Fortodyl; Mulsiferol; Calciferol; NSC 62792; Ergocalciferol; Radiostol
|
buco-D condocaps condol crystallina D-arthin D-tracetten davitin De-rat concentrate decaps dee-osterol dee-ron dee-ronal deltalin deratol detalup diactol divit urto doral drisdol ercalciol geltabs hi-deratol ergorone ertron metadee mina D2 mykostin NSC62792 NSC-62792 oleovitamin D oleovitamin D2 osteil ostelin radsterin rodine C shock-ferol sterogyl vio D viosterol vitamin D2 vitavel-D 7489-18-1 8017-28-5 31316-19-5 bones cancers hypertension immunity yeast fungi invertebrates vitamins ergosterol ultraviolet radiation organisms 25-hydroxyvitamin 25-hydroxy vitamin 1,25-dihydroxyvitamin 1,25-dihyrdroxyvitamin |
148.659649122807
|
| 11792 |
Vitamin D3
New
|
|
67-97-0 |
≥98%
|
|
|
2012-05-24
|
149.379884182525
|
vitamin-d3
|
Arachitol; Delsterol; Quintox; Granuvit D3; Lutavit D; NSC 375571; Ricketon; Cholecalciferol; Trivitan
|
calciol calcirol D3-vigantol decristol deparal devaron dry vitamin D3 100CWS/AM duphafral D3 1000 ekostop D3 FeraCol high-D 2X oleovit D3 oleovitamin D3 riken D3 oil 100 riken D3 oil 20 UVEDOSE Vi-
De3 videkhol vigantoletten vigorsan vitinc dan-dee-3 8024-19-9 8050-67-7 bones hypertension cancers immunity dietary fish 7-dehydrocholesterol ultraviolet lights metabolized 25-hydroxyvitamin 25- hydroxy vitamins 1,25-dihydroxyvitamins 1,25-dihydroxy vitamins cytochrome P450 CYP450 isoforms livers retinoid X receptors genes expressions |
149.379884182525
|
| 10010992 |
W123
Exclusive
|
|
- |
≥98%
|
|
✓ |
2008-11-14
|
61.497002762431
|
w123
|
|
FTY720 sphingosines sphingosine-1-phosphate receptors S1P S1P1 EDG1 EDG-1 inhibitors inhibits inhibition SEW2871 FTY 720 antagonist |
61.497002762431
|
| 10009110 |
W140 (trifluoroacetate salt)
|
|
- |
≥95%
|
|
|
2010-02-25
|
53.074986187845
|
w140-trifluoroacetate-salt
|
|
S1P sphingosine-1-phosphate sphingosines phosphates lymphocytes S1P1 antagonists immunity TFA |
53.074986187845
|
| 10009109 |
W146 (trifluoroacetate salt)
|
|
- |
≥95%
|
|
|
2010-03-10
|
75.952498465316
|
w146-trifluoroacetate-salt
|
|
S1Ps sphingosine-1-phosphates sphingosines phosphates lymphocytes S1P1 antagonists immunity capillary leakage antagonists GPCR G protein-coupled receptors S1P2 S1P3 S1P5 TFA salts
Phosphonic Acid Esters
Phosphonic Acids Phosphonates |
75.952498465316
|
| 13639 |
WZ811
|
|
55778-02-4 |
≥95%
|
|
|
2010-03-22
|
44.403024861878
|
wz811
|
|
CXC chemokines receptors CXCR4 stromal cell-derived factor-1 SDF-1 CXCL12 hematopoietic stem cells chemotaxis lymphocytes growth metastasis cancers T cells HIV infection inhibitors antagonist cAMP Matrigel invasion breast cancer adenocarcinoma inhibition alpha-Aminotoluene
alpha Aminotoluene
Phenylmethylamine
Benzylamines |
44.403024861878
|
| 13246 |
YM-58483
|
|
223499-30-7 |
≥98%
|
|
|
2009-11-16
|
5.369171270719
|
ym-58483
|
BTP 2
|
calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT |
5.369171270719
|
| 10011217 |
β-Defensin-2 (human recombinant)
|
|
- |
≥90%
|
|
|
2008-07-07
|
0.700994475138
|
-defensin-2-human-recombinant
|
hBD-2; Antimicrobial Peptide
|
E. coli defensins human .beta.-defensin human b-defensin antibiotics bdefensins immunomodulatory antiviral anti-microbal .beta.defensins Defensin 2.beta. Defensin 2b |
0.700994475138
|